ACG Wealth
STAB

ACG Wealth’s Statera Biopharma, Inc. Common Stock STAB Stock Holding History

ACG Wealth’s Portfolio STAB Stock Details STAB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q3 		– Sell
-1,250
Closed -$12K – 219
2014
Q2 		$12K Hold
1,250
– – ﹤0.01% 206
2014
Q1 		$17K Sell
1,250
-330
-21% -$5.37K 0.01% 182
2013
Q4 		$37K Buy
+1,580
New +$43K 0.01% 180

Other funds holding STAB

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SM
Sabby Management Miami Beach, Florida $111M AUM 74.4% 1-Year Est. Return
Ladenburg Thalmann Financial Services
Ladenburg Thalmann Financial Services Miami, Florida $15.9B AUM 25.16% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
California Public Employees Retirement System
California Public Employees Retirement System Sacramento, California $177B AUM 39.86% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return
BlackRock Advisors
BlackRock Advisors Wilmington, Delaware $98.8B AUM 15.8% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return

ACG Wealth's STAB Position: Q3 2014 in Review

ACG Wealth sold out of Statera Biopharma, Inc. Common Stock (STAB) in Q3 2014, closing a stake of 1,250 shares — an estimated $12K sold.

ACG Wealth first reported a position in STAB in Q4 2013 and held it in 3 quarters. The position peaked at $37K in Q4 2013. 25 funds tracked by Wall St. Rank hold STAB as of Q3 2014.

  • ACG Wealth reported no remaining Statera Biopharma, Inc. Common Stock position as of Q3 2014 after selling out during the quarter.
  • ACG Wealth sold 1,250 Statera Biopharma, Inc. Common Stock shares in Q3 2014, an estimated $12K.
  • ACG Wealth first reported a position in Statera Biopharma, Inc. Common Stock in Q4 2013 and held it in 3 quarters.
  • ACG Wealth's Statera Biopharma, Inc. Common Stock position peaked at $37K in Q4 2013.
  • 25 funds tracked by Wall St. Rank held Statera Biopharma, Inc. Common Stock as of Q3 2014.

Based on ACG Wealth's 13F filing for Q3 2014, filed 13 Nov 2014.